Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study. (Q47839413)

6 February 2018

title

Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study. (English)

1 reference

6 February 2018

0 references

5

1 reference

6 February 2018

Cornelia M. van Duijn

8

object named as

van Duijn CM

1 reference

6 February 2018

Albert Hofman

3

object named as

Hofman A

1 reference

6 February 2018

Christine Van Broeckhoven

6

object named as

Van Broeckhoven C

1 reference

6 February 2018

author name string

Slooter AJ

1

1 reference

6 February 2018

de Knijff P

2

1 reference

6 February 2018

Cruts M

4

1 reference

6 February 2018

Havekes LM

7

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

6 February 2018

published in

Neuroscience Letters

1 reference

6 February 2018

volume

248

1 reference

6 February 2018

page(s)

21-24

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900339-5

7 January 2021

Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900339-5

7 January 2021

Immunodetection of the amyloid P component in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900339-5

7 January 2021

Clinical-neuropathological correlations in Alzheimer's disease and related dementias

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900339-5

7 January 2021

Determinants of disease and disability in the elderly: The Rotterdam elderly study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900339-5

7 January 2021

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900339-5

7 January 2021

Distortion of allelic expression of apolipoprotein E in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900339-5

7 January 2021

Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900339-5

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900339-5

7 January 2021

Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900339-5

7 January 2021

Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900339-5

7 January 2021

Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900339-5

7 January 2021

The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900339-5

7 January 2021

Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900339-5

7 January 2021

Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900339-5

7 January 2021

10.1016/S0304-3940(98)00339-5

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

9665654

1 reference

6 February 2018